0.24
+0.0127(+5.66%)
Currency In USD
| Previous Close | 0.22 |
| Open | 0.23 |
| Day High | 0.24 |
| Day Low | 0.22 |
| 52-Week High | 2.65 |
| 52-Week Low | 0.17 |
| Volume | 313,195 |
| Average Volume | 684,778 |
| Market Cap | 4.17M |
| PE | -0.34 |
| EPS | -0.7 |
| Moving Average 50 Days | 0.25 |
| Moving Average 200 Days | 0.58 |
| Change | 0.01 |
If you invested $1000 in Hillstream BioPharma, Inc. (HILS) since IPO date, it would be worth $68.1 as of September 28, 2025 at a share price of $0.237. Whereas If you bought $1000 worth of Hillstream BioPharma, Inc. (HILS) shares 2 years ago, it would be worth $1,221.65 as of September 28, 2025 at a share price of $0.237.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl
GlobeNewswire Inc.
Sep 04, 2025 12:01 PM GMT
RED BANK, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Tharimmune, Inc. (Nasdaq: THAR), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and critical unmet medical needs anno